| Product Code: ETC6748730 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Non-Small Cell Lung Cancer Therapeutics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 China Non-Small Cell Lung Cancer Therapeutics Market - Industry Life Cycle |
3.4 China Non-Small Cell Lung Cancer Therapeutics Market - Porter's Five Forces |
3.5 China Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.6 China Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.7 China Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
4 China Non-Small Cell Lung Cancer Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence and prevalence of non-small cell lung cancer in China |
4.2.2 Growing awareness about advanced treatment options and therapies |
4.2.3 Rising healthcare expenditure and government initiatives to improve cancer care |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval process for new therapeutics |
4.3.2 High cost associated with advanced treatment options |
4.3.3 Limited accessibility to specialized cancer care facilities in rural areas |
5 China Non-Small Cell Lung Cancer Therapeutics Market Trends |
6 China Non-Small Cell Lung Cancer Therapeutics Market, By Types |
6.1 China Non-Small Cell Lung Cancer Therapeutics Market, By Therapy |
6.1.1 Overview and Analysis |
6.1.2 China Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Therapy, 2021- 2031F |
6.1.3 China Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.4 China Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.1.5 China Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2 China Non-Small Cell Lung Cancer Therapeutics Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 China Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 China Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.2.4 China Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2.5 China Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Non-Small Cell Lung Cancer Therapeutics Market, By Cancer Type |
6.3.1 Overview and Analysis |
6.3.2 China Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Adenocarcinoma, 2021- 2031F |
6.3.3 China Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Squamous cell carcinoma, 2021- 2031F |
6.3.4 China Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Large cell carcinoma, 2021- 2031F |
7 China Non-Small Cell Lung Cancer Therapeutics Market Import-Export Trade Statistics |
7.1 China Non-Small Cell Lung Cancer Therapeutics Market Export to Major Countries |
7.2 China Non-Small Cell Lung Cancer Therapeutics Market Imports from Major Countries |
8 China Non-Small Cell Lung Cancer Therapeutics Market Key Performance Indicators |
8.1 Patient survival rates post-treatment |
8.2 Adoption rates of innovative therapies |
8.3 Number of clinical trials for non-small cell lung cancer therapeutics in China |
9 China Non-Small Cell Lung Cancer Therapeutics Market - Opportunity Assessment |
9.1 China Non-Small Cell Lung Cancer Therapeutics Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.2 China Non-Small Cell Lung Cancer Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.3 China Non-Small Cell Lung Cancer Therapeutics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
10 China Non-Small Cell Lung Cancer Therapeutics Market - Competitive Landscape |
10.1 China Non-Small Cell Lung Cancer Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 China Non-Small Cell Lung Cancer Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here